Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Feasibility Study of Polymer Artificial Heart Valve for the Treatment the Mitral Valve Disease.

NCT: NCT07243184 · RECRUITING

NCT IDNCT07243184
StatusRECRUITING
Start Date2025-11-19
Completion2032-11
SponsorShanghai HeartEpoch Medical Technology Co., Ltd (INDUSTRY)
First posted
Last updated

Brief Summary

The study aims to evaluate the feasibility and safety of polymer artificial heart valve designed and developed by Shanghai HeartEpoch Medical technology Co. Ltd. for the treatment of the mitral valve diseases.

Frequently Asked Questions

What is The Feasibility Study of Polymer Artificial Heart Valve for the Treatment the Mitral Valve Disease.?

The Feasibility Study of Polymer Artificial Heart Valve for the Treatment the Mitral Valve Disease. is a clinical trial registered under NCT07243184. Current status: RECRUITING.

What is the status of NCT07243184?

The current status of NCT07243184 (The Feasibility Study of Polymer Artificial Heart Valve for the Treatment the Mitral Valve Disease.) is: RECRUITING.

When did The Feasibility Study of Polymer Artificial Heart Valve for the Treatment the Mitral Valve Disease. start?

The Feasibility Study of Polymer Artificial Heart Valve for the Treatment the Mitral Valve Disease. started on 2025-11-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑